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Background: Elderly in several European countries are currently being vaccinated against influenza and pneumococcal
disease, and various reasons have been put forward to expand these programs. To successfully immunize the older adult
population, however, it is crucial for the target group to accept such interventions. This study aims to elucidate the
motives of Dutch persons aged ≥50 years for accepting vaccination.
Methods: Thirteen focus groups were composed with persons aged 50 years and older. A semi-structured topic list with
open-ended questions was used to guide the focus groups. The transcripts were analyzed according the principles of
thematic survey. By an inductive process, the main themes and related subthemes were extracted from the responses.
Results: Eight themes were found to play an important role in accepting vaccination: healthy aging; usefulness of
vaccination in older age; risk of getting an infectious disease; vaccine characteristics; severity of the disease and its
implications; the experiences of previous vaccinations; the influence of healthcare workers and other people; and the
need for information.
Conclusions: This qualitative study reveals that acceptance of vaccination is not based on a single argument. The
most important one appears to be the risk of getting an infectious disease. In that light, vaccination campaigns
may emphasize the susceptibility of older adults. It is also advisable to consider the usefulness of vaccination in
older age as an overall argument. A tailored approach to offering vaccination may be considered. Further
research would be needed to determine the relative importance of the factors identified in this study.
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Europe is aging; it is estimated that by 2060, 28.4 % of
the population of the 27 Member States of the European
Union will be 65 years or older, compared to 18.6 % in
2014 [1]. As a result of immunosenescence (the gradual
deterioration of the immune system), co-morbidity, and
general frailty, this population is susceptible to infectious
diseases [2], resulting in higher mortality and morbidity
rates than in young adults [3]. Infections may lead to ir-
reversible frailty and thereby further dependency on
long-term healthcare [4]. At the same time, community-
dwelling older adults will be more socially engaged,
which increases the chance of transmission of infectious
diseases towards this population [5]. Apart from possible* Correspondence: renske.eilers@rivm.nl
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unless otherwise stated.benefits to individuals in this age group, vaccination may
yield social benefits such as lower overall costs of health-
care, as demonstrated by childhood vaccinations [6].
Several European countries offer elderly vaccination
against influenza and in some instances against pneumo-
coccal disease, tetanus, and diphtheria. In the Netherlands,
for example, influenza vaccination is offered to everyone
of 60 years or older and pneumococcal vaccine to groups
at risk. However, proposals have been made to expand the
Dutch immunization program for persons aged 60 years
and older to include pneumococcal disease, herpes zoster,
and pertussis [7].
For an immunization program to be successful and
produce the most health benefits, its acceptance is cru-
cial. It is therefore necessary to understand why the dif-
ferent reasons given by older persons accept or reject
vaccination. So far, no qualitative study has explored
these arguments for persons aged 50 years and older inhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the motives to accept or refuse vaccination among
community-dwelling persons aged 50 years and older
in the Netherlands.Methods
Participants and procedures
In total, 13 focus groups of individuals of 50 years or
older (n = 80) were composed. In a focus group, a person’s
view is clarified through interaction with other people,
which does not occur in an interview [8]. It was decided
to take 50 years as the cutoff point because of the possible
biological advantages of starting vaccination earlier in life
(e.g., stronger immune response).
A list of foundations for the welfare of older adults,
sheltered housing institutions, care homes, and residen-
tial groups across the Netherlands was compiled based
on an internet search. Locations were selected from this
list, whereby the geographical distribution and degree of
urbanization were taken into account to ensure nationwide
distribution and inclusion of individuals in both urban and
rural areas. In addition, two commercial agencies were
approached to recruit persons aged 50 and older. Letters
were sent out to the different organizations inviting
persons to participate in the study. Candidate respondents
received an information letter describing the background,
objectives, and procedures of the study and enclosing an
informed consent form.
Those willing to take part returned the form containing
their personal information. The participants ranged
from 52 to 92 years of age and were classified as livingTable 1 An overview of the age, sex and domestic situation per foc
Focus
group




1 9 0:9 3
2 7 1:6 5
3 8 2:6 0
4 7 0:7 1
5 7 3:4 0
6 9 1:8 0
7 6 2:6 0
8 3 1:2 0
9 7 1:6 0
10 5 1:4 0
11 7 1:6 0
12 3 2:1 0
13 2 0:2 0
Total 80 15 male:65 female 9
aMeans number of persons aged [..] and olderindependently (n = 31), in a residential group (n = 37), in a
care home (n = 2), or in sheltered housing (n = 10) (Table 1).Focus groups
The focus groups were convened between January and
November 2012. All 13 had the same moderator (RE),
accompanied by an assistant to take notes. The duration
of each session varied from 65 to 98 min. Every partici-
pant received a gift voucher of €20 after attending.
The groups were guided using a semi-structured open-
ended topic list (see Additional file 1). Since the aim was
to explore all opinions that arose, the questions were not
based on existing formats such as the Health Belief Model,
which might restrict the range of topics to be raised.
Each session started with an introduction to the research
and the aim of the focus group. The purpose of the study
was explained as follows to the participants: “In an aging
society, the prevalence of infectious diseases will rise.
Vaccination could protect older adults against several
infectious diseases and promote healthy aging. In that
light, it is important for us to know how you feel about
vaccination and what your reasons are to either accept
or reject vaccination.” In addition, the group members
were asked permission to record the session.
The participants were then asked to give their thoughts
on vaccination in general and to write down the pros and
cons of accepting vaccination. This topic covered not only
influenza vaccination but also, expansion of the current
program to include vaccines for herpes zoster, pneumo-
coccal disease, and pertussis. Their views were discussed








4 0 2 Living independent
2 0 0 Living independent
2 3 3 Residential group
3 3 0 Residential group
5 2 0 Residential group
1 7 1 Residential group
0 5 1 Residential group
1 0 2 Sheltered housing
0 4 3 Sheltered housing
4 1 0 Living independent
6 1 0 Living independent
1 0 2 Living independent
0 0 2 Care home
29 26 16
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special attention to the role of the general practitioner.
Analysis
All sessions were recorded with a digital voice recorder
and the recordings were transcribed verbatim. The tran-
scripts were analyzed with the software program Nvivo
(QSR International) according to the principles of the-
matic survey [9]. Themes and subthemes were extracted
by an inductive process. All of the transcripts were
coded by the moderator (RE); afterwards, one was also
coded by an independent researcher (IH). Coding con-
sisted of labeling passages with concepts abstracted from
this text. The results were compared, discussed, and re-
fined until consensus was reached on the coding scheme
and the labelling criteria. As the schemes of RE and IH
were almost identical, consensus was achieved. By coin-
cidence, the participants in some focus groups were pre-
dominantly 70 years and older, whereas those in other
groups were predominantly between 50 and 70. There-
fore, efforts were made to perform some data analysis
based on age by comparing the concepts identified in
the transcripts of these focus groups, referred to as older
and younger participants.
Results
The views on healthy aging and the main factors influen-
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Fig. 1 An overview of the themes and factors identified during the focus gare discussed below and illustrated by quotes from dif-
ferent focus groups. The results are presented in three
main topics: general views on healthy aging; reflections
on whether to accept or reject vaccination; and condi-
tions that have to be met before accepting vaccination.
Each topic covers several themes that were probed dur-
ing the focus groups. The general views refer to ‘healthy
aging’ and ‘usefulness of vaccination in older age’. The
reflections were identified as ‘the risk of getting an infec-
tious disease’, ‘vaccine characteristics’, ‘severity of the
disease’, ‘experience of previous vaccinations’, and ‘the
influence of the healthcare worker and other people’.




There was consensus that aging is something one under-
goes but that how one ages can be influenced, for ex-
ample by taking care of one's body. Healthy living was
specified as eating healthy food, exercising, getting enough
sleep, and having no stress. “Well, one can’t do more than
lead a healthy life. Eat regular meals, and the rest comes
naturally, one can’t control that. Everything else just comes
by itself.” (focus group 9, female, sheltered housing) It was
acknowledged that ailments come with aging; the crux is
coping with them: “As for aging gracefully, everyone gets
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(focus group 7, female, residential group)
They did, however, distinguish between physical and
mental dimensions, whereby mental problems (such as
Alzheimer’s) were perceived as more severe. As one woman
said, “Because to me, the worst thing that can happen to
you is … with your mind.” (focus group 12, female,
independent)
The participants defined healthy aging as remaining
independent and self-reliant. It was important for them
to actively take part in society, engage in social contacts,
and have a meaningful life. There was no consensus on
whether vaccination could contribute to healthy aging.
So even though they spoke about preventing disease by
healthy living, not all considered vaccination as a part of
this lifestyle: “Well, but that is unnatural prevention.”
(focus group 1, female, independent) To some, accepting
a vaccine was part of taking responsibility for your
health and doing the best you can: “Anyway, even if it
does not help, at least you tried and that is encouraging.”
(focus group 8, male, residential group)
To others, vaccination was part of healthy aging. Some
took it for granted and made a habit of accepting the in-
fluenza vaccine. Others felt that ‘it doesn’t hurt to try’,
which coincides with the saying ‘prevention is better than
cure’ mentioned by a few participants. They just wanted
to stay healthy and prevent disease: “I am in favour
because it is part of overall prevention. Prevention is
better than cure.” (focus group 10, male, independent)
A.2 Usefulness of vaccination in older age
One important aspect that was brought up was the use-
fulness of vaccination at an older age. This was related
to the fact that life is finite. Some participants felt you
should let nature run its course instead of trying to pre-
vent the inevitable: “You have to die of something.” (focus
group 1, female, independent) Especially the older par-
ticipants felt that prolonging life is not always the right
choice.
Another concern was whether they would feel they
had lived life to the fullest: “Well yes, but if you feel your
life is not yet complete, that there are still things you
need to do for yourself, then I think it is alright to try to
stretch it with an injection of something or other.” (focus
group 3, female, residential group) Some participants
had doubts about prolonging life without adding any
quality to it. In addition, death was sometimes seen as
deliverance, especially when somebody is already suffer-
ing. These participants also spoke of pneumonia being
the old man’s friend: “And it makes a difference how you
age. And let’s face it, there comes a time when death can
be a blessing.” (focus group, female, independent)
A different issue that was raised is wanting to age
without any interventions (such as vaccines). This isrelated to the notion that ailments go hand in hand with
age. To some participants, the perspective of having
more vaccines available in the future was indicative of a
medicalization of aging: “Just let us grow old in an ordin-
ary way. And we don’t necessarily all have to reach 90.”
(focus group 5, female, residential group)
B. Reflections on whether to accept vaccination
When considering whether to accept a vaccine, people
reflected on several issues. The following sections discuss
factors that appear to be important when deciding whether
to accept vaccination.
B.1 Risk of getting an infectious disease
The risk of getting an infectious disease seems to be one
of the most important factors. It was not often men-
tioned explicitly but came up as a topic of concern, with
multiple aspects as shown below.
B.1.1. Vulnerability The first aspect is whether partici-
pants felt vulnerable to infectious disease. In general,
they did not, even though their age in itself put them at
risk. More important to them was their health status at
the time of vaccination: “What matters is your general
state of health. Are you already chronically ill with one
thing or another?” (focus group 1, female, independent)
In the event of feeling healthy, the participants saw
two possible actions: they would either accept vaccin-
ation in order to stay healthy, or they would reject it be-
cause they would feel healthy enough to fight the
infection. This latter argument was expressed by partici-
pants who have confidence in their bodies because of
their healthy lifestyle: “I believe I’m healthy enough to
deal with a possible bout of flu, and then I think it is not
really necessary.” (focus group 3, female, residential group)
In the event of feeling unhealthy, the participants
mentioned two possible actions: to accept vaccination
because they would feel vulnerable and be worried about
their health; or to reject it because they would already
be taking medication for co-morbidities and would not
want the extra hassle. One participant spoke about being
afraid that her body could not cope with an extra inter-
vention due to the medications she was already taking:
“I just happen to think that I might be getting too much,
these are all kinds of chemicals that your body has to
deal with, and then you get something like this on top of
it all.” (focus group 9, female, sheltered housing)
B.1.2. Prior sickness The second aspect is whether the
participants had previous encounters with infectious dis-
ease. This includes personal experience, meaning having
been ill themselves or seeing someone else get sick.
Experience would have two possible effects on one’s
willingness to be vaccinated. If people had been ill
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more vulnerable and were more inclined to accept
immunization for this particular infectious disease:
“But I have had pneumonia two or three times already.
And then, if you are given that advice, well, then you go
along with it.” (focus group 6, male, residential group)
On the other hand, participants without such experi-
ence did not consider themselves vulnerable at all and
therefore wondered why they should accept the vaccine:
“Never been ill a day in my life, I never had the flu, so
why should I do it now?” (focus group 6, female, residen-
tial group)
It appeared that the younger participants tend not to
feel vulnerable to infectious disease because of their
healthy lifestyle, and fewer had experienced episodes of
sickness.
B.1.3. Epidemic In the case of an epidemic, vaccines
would be more easily accepted because the infectious
disease would be widespread in the population, increas-
ing the chance of contracting it.
B.2 Characteristics of the vaccine
Besides personal factors, the characteristics of the vaccine
were also part of the deliberation on whether to accept or
reject a vaccine. These characteristics are its effectiveness
and its side effects.
B.2.1. Vaccine effectiveness Though acknowledging
that 100 % effectiveness is difficult to achieve, the partic-
ipants considered the effectiveness important. They men-
tioned it mainly in connection with influenza. “Just like X
said, viruses can also mutate very quickly, so you can never
be assured that you won’t get the flu.” (focus group 5,
female, residential group) Those who were hesitant to get
a flu shot felt it would not protect them because the vac-
cine only covers a few of the existing viruses. In addition,
some wondered whether the immunity acquired from a
vaccine is as strong as that acquired from undergoing the
disease: “And even so, if I go in for a shot with not a very
strong dose, will my immune system then be activated
enough? Wouldn’t I just be kidding myself?” (focus group
2, male, independent)
In general, the minimum effectiveness for acceptance
of a vaccine varied from 50 to 70 percent. This rate re-
flects the severity of the disease: the more severe, the
more willing the participants were to accept a vaccine
with a lower effectiveness. In addition, some participants
did not consider prevention to be the main effect of
vaccination. They said it could also make them less ill
or reduce the amount of time they would be sick: “Even
if you can reduce your risk by 50 % that would already
be a great improvement. See, 100 % risk-free is justhypothetical, it is just not realistic.” (focus group 9, female,
sheltered housing)
B.2.2. Side effects of the vaccine Another important
aspect is the possibility of side effects. In general, side ef-
fects were accepted as part of vaccination. In any event,
mild side effects were never considered a problem. As
one woman put it: “Now, a red spot on your arm is no
big deal, it could start hurting; well, then you just put a
wet cloth around it and that takes care of that.” (focus
group 13, female, care home)
However, if the side effects would interfere with every-
day life, the acceptance rate could be much lower: “But
if I would really be affected and I would have to stay in
bed for three or four days because I would feel miserable,
then I suppose I’d decline. I wouldn’t do anything like
that.” (focus group 8, female, sheltered housing)
Some participants doubted they would take the risk of
potential severe side effects if they did not know whether
they would actually get the disease. They compared vac-
cines with medications: “Oh, well. Look, if you are sick
and you know that it will cure you, then you do go along
with it. But I mean, if you are not very sick yet and you
know that you will get seriously ill from the injection,
then I don’t know if I would want to take that risk.”
(focus group7, female, residential group)
In three focus groups, the participants also spoke
about the content of the vaccine. Specifically, they be-
lieved that vaccines contain (poisonous) substances that
diminish the functioning of the immune system. One
participant expressed her feelings as follows: “And then
the dangers of it, because, yes, so there are … see, they
don’t say much about it but so many poisonous sub-
stances are added to the vaccine and these are all stored
up in your body, they poison your body, which means
that your immunity is lowered even further.” (focus group
4, female, residential group) There were also concerns
about the impact of receiving more than one vaccine.
B.3 Severity of the disease and its implications
B.3.1. Perceived severity Another consideration was the
severity of the infectious disease that the vaccine would
protect against. Participants would accept vaccination
against diseases that would affect their quality of life,
increase mortality, cause suffering, produce pain and
discomfort, or lead to invalidity. One participant sum-
marized it as follows: “I think this applies to all of us.
As for me, it is at the top of the list. Health risks. I mean,
to me that is a real concern, it determines whether or not
I’ll take that shot.” (focus group 2, male, independent)
Interestingly, when participants were asked how severe
a disease had to be in order to accept a vaccine against
it, most of the time they mentioned a mental illness,
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consider physical problems less important and thus less
severe. As one woman put it, “If there would be an injec-
tion against Alzheimer’s, I wouldn’t hesitate a moment!”
(focus group 1, female, independent)
One woman also compared the severity of the infec-
tious diseases discussed in the focus group with those
that are in the National Immunization Program (NIP).
She concluded that it is more important to vaccinate
against childhood diseases in light of their severity: “It
also depends on how serious the disease is; for children
you can’t take the risk of whooping cough and polio. But
for the flu or pneumonia, I think those illnesses are not
so serious, well, unless they kill you, of course; normally
the inoculation is worse. That is really the decision you
have to make. To prevent polio and all those other child-
hood diseases, you just have to get the shots. Because the
risks are too great. But considering the flu and pneumonia,
that is not so clear.” (focus group 1, female, independent)
Others included the number of times one gets the dis-
ease in the degree of severity that influences the decision
to accept vaccination: “Well, I think if you get pneumonia
once, you don’t immediately drop dead, but if you get it
time and again, year after year, then I guess I would be will-
ing to get vaccinated.” (focus group 1, female, independent)
And last, this perception of the severity of a particular
infectious disease can be influenced by personal experi-
ence and observing the disease burden on someone
else. One woman recounted her husband’s experience
of pneumonia: “Really, my husband had it too. I can tell
you, you don’t want to see that happen!” (focus group 1,
female, independent)
Two specific reasons to accept vaccination concern
the implications of the severity of the disease. These
implications were the probability of contagion, and
therefore wanting to protect others, and losing one’s
independence.
B.3.2. Protection of others Besides accepting a vaccine
to protect oneself against infectious disease, the partici-
pants were also willing to protect people around them,
especially their grandchildren and vulnerable spouses:
“Especially if you have grandchildren and you know that
you are exposing them, then I would always do it, you
know.” (focus group 3, female, residential group) In the
same light, people would accept vaccination to prevent
becoming sick because of their role in caring for other
people. For some, that was the decisive reason to accept
the vaccine.
On the other hand, some participants were wary of be-
ing tricked into guilt feelings if they rejected the vaccine.
“But we should not be talked into feeling guilty. Because
if you don’t participate … .” (focus group 5, male, resi-
dential group) Related to this is the perceived obligationto accept vaccination felt by some of the participants
who work with vulnerable people, for example in a nursing
home. As one woman explained, “Well, for me that was the
reason to accept a flu shot, because you are always working
with older people, who are more vulnerable after all.” (focus
group 11, female, independent) This perceived obligation
might be imposed by others: for example, a spouse who
needs to be vaccinated in order to babysit for the grand-
children. Participants concluded that vaccination should
remain voluntary if the immunization program were to be
expanded.
B.3.3. Staying independent Getting an infectious disease
could mean losing some independence. The importance of
remaining independent was also reflected in the discussion
about vaccination. As one participant said, “No, but you
want to remain independent as long as possible, and to me
that is a reason to be vaccinated.” (focus group 11, female,
independent) This was especially important for people
without a partner. Becoming ill meant that it is more diffi-
cult to take care of themselves, and they didn’t want to
burden others by asking them to help out. Moreover, they
wanted to keep participating and contributing to society.
Vaccination could be a means to fulfill this desire: “It can
help you to stay healthy, to be able to participate fully
in society.” (focus group 10, male, independent)
B.4 Experiences with previous vaccinations
Another consideration is whether previous vaccination
experiences were either positive or negative. Negative ex-
periences with the influenza vaccine led to more hesitation
about accepting the next influenza vaccination and per-
haps other vaccines as well. One woman told about her
experience with the influenza vaccine and its side effects:
“And that is exactly why I often thought that I would not
do it again, because it always makes me so sick.” (focus
group 11, female, independent) Experience matters not
only with respect to the possible side effects of a vaccine
but also to its perceived effectiveness. “I believe that I will
always get my flu shot, because yes, put simply, it works, in
my view, I never catch the flu. And when that vaccination
was not available, before I got those shots, I did indeed
catch the flu once. Clearly, experience counts.” (focus
group 3, female, residential group)
B.5 External influence
Two categories of people were identified that influence
the decision on whether to accept a vaccination: one’s
general practitioner (GP); and one’s friends and family.
B.5.1 The general practitioner The GP plays an import-
ant part in the participants’ decision to accept vaccination
or not. In the Netherlands, it is currently the GP who in-
vites individuals to come in for an influenza vaccination.
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meaning that the GP’s advice is the main reason, and
sometimes the only one, to accept or reject vaccination.
Having a good relationship with one’s physician and trust-
ing him or her is essential: “That letter, the invitation to
come in for the flu shot, that comes from (…). That is my
doctor, and I trust my doctor for 500 %. Period!” (focus
group 3, female, residential group) Even when a partici-
pant was initially against vaccination; “then my doctor
convinced me to do it, yes.” (focus group 13, male, inde-
pendent). In addition, participants attached great value
to the fact that the GP knows their medical condition.
They therefore considered their family doctor as the
right person to decide whether vaccination is necessary:
“To my mind, he is in the right position to say whether
or not it is useful because he knows all your ailments;
has the right picture of you.” (focus group 2, male,
independent)
The second active role is an advisory one, meaning
that a person will ask the GP for advice, though not ne-
cessarily take it. It is added to the rest of the information
people gather to make their decision: “I think it is right,
but I also have my own opinion. I would not blindly
follow his advice.” (focus group 7, female, residential
group)
Especially the older participants saw the GP as a leader
and were more inclined to follow his or her recommen-
dations. The younger participants were less inclined to
see the GP as a leader, and they would make their own
decision.
And last, some felt that the GP has nothing to do with
their decision to accept vaccination: “I make my own de-
cision, because I form my own opinion of what to do, I
make up my own mind, I don’t need the doctor for that.”
(focus group 3, female, residential group)B.5.2 Friends and family In addition to the GP, other
individuals also play a role, though to a lesser extent.
These are family and friends. Their role involves talking
about vaccination more than giving advice, but especially
discussing the experiences, either positive or negative,
that influence one’s decision to be vaccinated or not.
The conversations can either cast doubt on the effective-
ness of the vaccine or reinforce a positive attitude.C. Conditions before vaccination is accepted
C.1 The need for and influence of different information sources
Besides discussing the various factors that play a role in
decision-making, the participants also spoke about the
information they would want to receive when a vaccine
is offered to them. Obtaining this information is seen as
a condition for accepting any vaccination. The participants
stressed the need for information about the vaccines:“Obviously, we are not guinea pigs.” (focus group 1, female,
independent)
Several sources of information were suggested. One
idea was to enclose a fact sheet, like the one given with
medications, along with the invitation for vaccination.
Then the participants would know what to expect, espe-
cially regarding the side effects. In addition, other sources
of information were discussed, with the GP being the
most important one: “Yes, I would take this up with my
doctor, or … Because that would be the right person to pro-
vide more information, like how it could turn out, right?”
(focus group 4, female, residential group)
Participants would also search the internet for informa-
tion and turn to reports on television and in the newspa-
pers. However, these public sources have a different effect
on the willingness to accept vaccination and could lead
to negative attitudes. Some participants spoke about their
mistrust of the medical profession, sparked by reports that
money had been earned with the Mexican flu vaccination.
Some participants expressed a dislike of the pharmaceut-
ical industry because of this. “And then there are those
publications, on television and in the newspapers, saying
that it was all greed, and yes, that made me quite hesitant.
I thought, should I go along with it or not? That is obvi-
ously not the right thing to do.” (focus group 5, male, resi-
dential group)
As a consequence, the participants wanted a guarantee
that information coming from the GP or the government
is objective, independent, and research-based. Some par-
ticipants did express confidence in the government and
the medical profession: “If I could get such a vaccination
somewhere, then I would go for it. And if it wouldn’t do
any good, they wouldn’t be offering it; that is the only thing
I wrote down.” (focus group 10, female, independent)Discussion
We identified eight themes that influence the decision of
persons aged 50 years and older to accept vaccination.
These are healthy aging, usefulness of vaccination in older
age, risk of getting an infectious disease, vaccine character-
istics, severity of the disease, experiences of previous
vaccinations, influence of healthcare workers and other
people, and need for information.
Vulnerability to infectious diseases as experienced by
the participants and the usefulness of vaccination in older
age seem to be the most important factors influencing the
decision to accept a vaccine. Concerning vulnerability, the
participants fall into two distinct groups. The first did not
feel vulnerable to infectious diseases, often due to their
healthy lifestyle. The second did feel vulnerable because
they suffer from chronic disease, have themselves already
experienced disease previously, or someone near to them
had. This is an important finding because the core
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their biological susceptibility to infection [2].
With regard to the usefulness of vaccination in older
age, it were mostly the older participants who expressed
doubts. Questions were raised about vaccines that could
prolong life. Life is seen as finite; it should not be pro-
longed at all costs, especially when death could bring de-
liverance from suffering. In addition, the participants felt
that aging should occur normally without any interven-
tions. They saw more need for vaccination at a younger
age, though this would depend on one’s health status at
the time of vaccination.
The usefulness of vaccination in older age is scarcely
treated in the literature [10]. We feel that this theme
came to light because of our explorative design and the
fact that the study concerns not only the current offerings
but also adding more vaccines to the program. Partici-
pants were asked to give all reasons they might have for
accepting vaccinations (not only influenza immunization)
instead of asking about specific ones. This might have
given the participants a cue to take a broader perspective,
allowing umbrella arguments to come to mind.
Furthermore, as part of the theme of severity of the
disease and its implications, the motive of wanting to
protect others emerged in the focus groups as a reason
to accept vaccination. This is another topic that has not
been addressed in other studies. It is briefly touched upon
in Kwong et al. [11]. There, the participants believed the
vaccine would protect themselves and their family around
them, especially the grandchildren. Also in our study, the
participants expressed a need for vaccination in order
to babysit for their grandchildren and to comply with
the wishes of their children, as well as to protect their
ill spouses. It is not clear why this topic was pronounced
in our study but less so in others. It might reflect the
increasing attention given to vaccinating adults in the
Netherlands in recent years, after the Health Council
released a report on moving toward a vaccination pro-
gram for all ages [12]. This may have raised awareness
of immunization among general practitioners, which in
turn could have led to offering more vaccinations or
giving more information on the availability of vaccines.
The motive of protecting others could be useful when
considering vaccination against whooping cough (pertussis),
which was regarded as a terrible childhood disease. The
participants were often willing to accept pertussis vac-
cine in order to protect their grandchildren from it.
Overall, in contrast to our findings, (dis)trust in medi-
cine and medical personnel and in the health services in
general is often mentioned in the literature, notably in
the studies of Telford and Rogers, Harris and Evans
[13–15]. Also, in contrast to others who found that lo-
gistic problems and/or financial barriers could impede the
acceptance of vaccination [16], our study did not identifyany logistic problems. This divergence might be related to
the fact that in the Netherlands the influenza vaccine is
provided by the general practitioner. Logistics are there-
fore not much of an issue because 75 % of the population
have access to their GP within less than a kilometer [17].
Furthermore, influenza vaccine is given free of charge,
which could explain why cost is irrelevant to the partici-
pants in our study.
The findings of our qualitative study still need to be
explored quantitatively. Nonetheless, our results suggest
that targeted messages or personalized vaccination could
be the key to a high vaccination uptake when offering
older adults other vaccines alongside the existing influ-
enza vaccination program. Information should be object-
ive and independent. Information providers should also
take into account that younger and older people may
have different attitudes on some of the factors that were
identified and illustrated in this study. Given that some
older adults seem not to prefer prolonging life but would
rather pursue quality of life, they might be more motivated
to accept herpes zoster vaccination than pneumococcal
vaccination. Although others might have the opposite in-
clination toward these vaccines, our findings indicate that
the focus should not be solely on prolonging life.
Second, the participants did not feel vulnerable in gen-
eral. Every person has a risk of infection at some time in
life. However, older adults have an extra risk factor, namely
their age. In order to give older adults the opportunity to
fully profit from available vaccinations, this risk informa-
tion could be shared. The ideal person to provide such in-
formation would be their GP. He or she has records of
disease history and other information on patients in their
clinics that would give them the background for a more
precisely targeted advice. Moreover, the GP is by definition
an important person in the decision-making process
of older adults, as shown by our study especially for
the elderly.
However, the younger participants preferred to rely on
the internet for guidance in their decision on whether to
accept vaccination. Special attention is therefore needed
to ensure that appropriate information is easy accessible
on the internet. Nevertheless, it still has to be recognized
that some participants did not consider vaccination use-
ful in older age.
Whereas most studies consider vaccination programs
in their current composition, we looked into adding
vaccines to existing influenza programs. Examples of po-
tential additions are herpes zoster vaccine, pertussis vac-
cine, and most notably pneumococcal vaccine. A particular
strength of this study is its broad explorative design. No
pre-specified models were used to guide the topics that
would be raised in the focus groups. This allowed the
participants to speak freely about vaccination. That might
explain why some themes that had not been covered
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vaccination in older age.
There are also a few limitations to this study. Unfortu-
nately, we did not gather demographics on the participants
except for their age and residential setting. Had we done
so, we would have been able to distinguish between the
individual participants and their views on vaccination.
Furthermore, the persons who participated in the focus
groups were probably already interested in research, which
could imply a selection bias. In addition, the gender distri-
bution was not balanced, with 65 women and 15 men, so
the attitudes of men are underexposed.
We tried to recruit a representative sample by inviting
persons aged 50 years and older from different residential
settings across the Netherlands. Unfortunately, we were
only able to recruit two persons living in a care home. We
approached several care homes, but the administrators
usually refused to cooperate because the residents were
not deemed able to participate.
Ideally we would like to have selected the participants
randomly. However, this was not feasible because of the
focus-group setting. The participants may have had to
make arrangements for long travel and we would have
needed enough individuals to form the focus groups.
Three of the 13 focus groups had less than the minimum
of five participants, but the shortfall was due to illnesses
on the day they were convened. It is unfortunate that
with this recruitment method it is not known how many
persons were invited to take part, but we feel this was
the most feasible approach.
Last, seven of the 13 focus groups were convened at a
time when the media carried frequent reports on the
role the pharmaceutical industry allegedly played in the
provision of vaccines. This publicity could have influenced
the results of our study because, as mentioned earlier, the
participants would gather some of their information from
the media. Still, mistrust was not found to be a key theme
in this study, so the media influence may be considered
low.
Conclusions
In conclusion, this qualitative study shows that the decision
to accept vaccination is based not on a single argument
but on multiple. The absence of perceived susceptibility
seems to be the most important reason to reject vaccin-
ation. It is important to realize that the views of persons
50 years and older might be age-related. Furthermore,
some of their views on health might relate to their inten-
tions regarding vaccination and their preferences for
specific vaccines (i.e., protecting quality of life versus
life prolongation). In that light, a targeted or even per-
sonalized approach might be the most suitable way to
encourage older adults to accept vaccination offers. More-
over, the usefulness of vaccination in older age must betaken into consideration. These observations warrant
further exploration in future research.
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